Growth Metrics

Steris (STE) Cost of Revenue (2018 - 2025)

Steris has reported Cost of Revenue over the past 8 years, most recently at $840.7 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $840.7 million for Q4 2025, up 10.59% from a year ago — trailing twelve months through Dec 2025 was $3.3 billion (up 6.67% YoY), and the annual figure for FY2025 was $3.1 billion, up 4.66%.
  • Cost of Revenue for Q4 2025 was $840.7 million at Steris, up from $814.4 million in the prior quarter.
  • Over the last five years, Cost of Revenue for STE hit a ceiling of $840.7 million in Q4 2025 and a floor of $493.7 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $711.9 million (2021), compared with a mean of $700.7 million.
  • Biggest five-year swings in Cost of Revenue: surged 68.19% in 2021 and later fell 15.07% in 2022.
  • Steris' Cost of Revenue stood at $670.9 million in 2021, then fell by 5.46% to $634.2 million in 2022, then increased by 16.31% to $737.7 million in 2023, then grew by 3.05% to $760.2 million in 2024, then rose by 10.59% to $840.7 million in 2025.
  • The last three reported values for Cost of Revenue were $840.7 million (Q4 2025), $814.4 million (Q3 2025), and $763.1 million (Q2 2025) per Business Quant data.